Table: begin end state 1 64 cytoplasmic 65 85 transmembrane 86 90 non-cytoplasmic 91 107 transmembrane 108 143 cytoplasmic 144 166 transmembrane 167 170 non-cytoplasmic 171 189 transmembrane 190 197 cytoplasmic 198 220 transmembrane 221 241 non-cytoplasmic 242 264 transmembrane 265 284 cytoplasmic 285 306 transmembrane 307 318 non-cytoplasmic 319 344 transmembrane 345 375 cytoplasmic 376 398 transmembrane 399 403 non-cytoplasmic 404 423 transmembrane 424 443 cytoplasmic 444 465 transmembrane 466 470 non-cytoplasmic 471 490 transmembrane 491 506 cytoplasmic
Input: >H281DRAFT_04042 VPVRCKKSAGWYQYLGNIGRGKIFGSAGADHKSGRAIEIHTLGRNLDNALQQDGLKRGLK NRHIQLIALGGAIGTGLFLGSASVLQAAGPSMILGYAIGGVIAFMIMRQLGEMVAQEPVA GSFSHFAYKYWGDFPGFLSGWNYWVLYVLVSMAELTAVGTYVHYWWPGVPTWVSALVCFA GINAINLANVKAYGETEFWFAIIKVVAVIGMILFGGYLLVSGHGGPQASISNLWSHGGFF PHGFHGLFTMLAVIMFSFGGLELIGITAAEADEPQKSIPKAVNQVIYRILIFYICSLAVL LSLYPWNEVAAGGSPFVMIFSQIGSTLTANVLNVVVLTAALSVYNSGVYANSRMLYGLAE QGNAPRALMKVDRRGVPYMAIGLSALATFTCVIVNYLIPAEALGLLMALVVAALVLNWAL ISLTHLKSRRAMVAAGETLVFKSFWFPVSNWICLAFMALILVILAMTPGLSVSVLLVPVW LVVMWAGYAFKRRRAAAHVAARVVGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server